|
1
|
Ennour-Idrissi K, Maunsell E and Diorio C:
Telomere length and breast cancer prognosis: A systematic review.
Cancer Epidemiol Biomarkers Prev. 26:3–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dhennin-Duthille I, Gautier M, Faouzi M,
Guilbert A, Brevet M, Vaudry D, Ahidouch A, Sevestre H and
Ouadid-Ahidouch H: High expression of transient receptor potential
channels in human breast cancer epithelial cells and tissues:
Correlation with pathological parameters. Cell Physiol Biochem.
28:813–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pieta B, Chmaj-Wierzchowska K and Opala T:
Life style and risk of development of breast and ovarian cancer.
Ann Agric Environ Med. 19:379–384. 2012.PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christofori G: Cancer: Division of labour.
Nature. 446:735–736. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Podsypanina K, Du YC, Jechlinger M,
Beverly LJ, Hambardzumyan D and Varmus H: Seeding and propagation
of untransformed mouse mammary cells in the lung. Science.
321:1841–1844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akashi T, Koizumi K, Tsuneyama K, Saiki I,
Takano Y and Fuse H: Chemokine receptor CXCR4 expression and
prognosis in patients with metastatic prostate cancer. Cancer Sci.
99:539–542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu TP, Shen H, Liu LX and Shu YQ: The
impact of chemokine receptor CXCR4 on breast cancer prognosis: A
meta-analysis. Cancer Epidemiol. 37:725–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wald O, Shapira OM and Izhar U:
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic
roles and therapeutic potential. Theranostics. 3:26–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, et al: CXCR7 (RDC1) promotes breast and lung tumor growth
in vivo and is expressed on tumor-associated vasculature. Proc Natl
Acad Sci USA. 104:pp. 15735–15740. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Shiozawa Y, Wang J, Wang Y, Jung
Y, Pienta KJ, Mehra R, Loberg R and Taichman RS: The role of
CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate
cancer. J Biol Chem. 283:4283–4294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marchesi F, Monti P, Leone BE, Zerbi A,
Vecchi A, Piemonti L, Mantovani A and Allavena P: Increased
survival, proliferation, and migration in metastatic human
pancreatic tumor cells expressing functional CXCR4. Cancer Res.
64:8420–8427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sutton A, Friand V, Brulé-Donneger S,
Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer
M, Vassy J, et al: Stromal cell-derived factor-1/chemokine (C-X-C
motif) ligand 12 stimulates human hepatoma cell growth, migration,
and invasion. Mol Cancer Res. 5:21–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burns JM, Summers BC, Wang Y, Melikian A,
Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ,
et al: A novel chemokine receptor for SDF-1 and I-TAC involved in
cell survival, cell adhesion, and tumor development. J Exp Med.
203:2201–2213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mazzinghi B, Ronconi E, Lazzeri E,
Sagrinati C, Ballerini L, Angelotti ML, Parente E, Mancina R, Netti
GS, Becherucci F, et al: Essential but differential role for CXCR4
and CXCR7 in the therapeutic homing of human renal progenitor
cells. J Exp Med. 205:479–490. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perlin JR and Talbot WS: Signals on the
move: Chemokine receptors and organogenesis in zebrafish. Sci STKE.
2007:pe452007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gerrits H, van Ingen Schenau DS, Bakker
NE, van Disseldorp AJ, Strik A, Hermens LS, Koenen TB,
Krajnc-Franken MA and Gossen JA: Early postnatal lethality and
cardiovascular defects in CXCR7-deficient mice. Genesis.
46:235–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Q, Zhang A, Tao C, Li X and Jin P: The
role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose
tissue-derived mesenchymal stem cells in vitro. Biochem Biophys Res
Commun. 441:675–680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng K, Li HY, Su XL, Wang XY, Tian T, Li
F and Ren GS: Chemokine receptor CXCR7 regulates the invasion,
angiogenesis and tumor growth of human hepatocellular carcinoma
cells. J Exp Clin Cancer Res. 29:312010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh RK and Lokeshwar BL: The
IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling
to promote prostate cancer growth. Cancer Res. 71:3268–3277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao M, Zheng J, Hou K and Wang J, Chen X,
Lu X, Bo J, Xu C, Shen K and Wang J: Role of chemokine receptor
CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xue TC, Chen RX, Han D, Chen J, Xue Q, Gao
DM, Sun RX, Tang ZY and Ye SL: Down-regulation of CXCR7 inhibits
the growth and lung metastasis of human hepatocellular carcinoma
cells with highly metastatic potential. Exp Ther Med. 3:117–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kollmar O, Rupertus K, Scheuer C, Nickels
RM, Haberl GC, Tilton B, Menger MD and Schilling MK: CXCR4 and
CXCR7 regulate angiogenesis and CT26.WT tumor growth independent
from SDF-1. Int J Cancer. 126:1302–1315. 2010.PubMed/NCBI
|
|
25
|
Bauerle KT, Schweppe RE, Lund G, Kotnis G,
Deep G, Agarwal R, Pozdeyev N, Wood WM and Haugen BR: Nuclear
factor κB-dependent regulation of angiogenesis, and metastasis in
an in vivo model of thyroid cancer is associated with secreted
interleukin-8. J Clin Endocrinol Metab. 99:E1436–E1444. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin Y, Zhou Z, Zhang F, Wang Y, Shen B,
Liu Y, Guo Y, Fan Y and Qiu J: Induction of regulatory B-cells by
mesenchymal stem cells is affected by SDF-1α-CXCR7. Cell Physiol
Biochem. 37:117–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou SM, Zhang F, Chen XB, Jun CM, Jing X,
Wei DX, Xia Y, Zhou YB, Xiao XQ, Jia RQ, et al: miR-100 suppresses
the proliferation and tumor growth of esophageal squamous cancer
cells via targeting CXCR7. Oncol Rep. 35:3453–3459. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Inaguma S, Riku M, Ito H, Tsunoda T, Ikeda
H and Kasai K: GLI1 orchestrates CXCR4/CXCR7 signaling to enhance
migration and metastasis of breast cancer cells. Oncotarget.
6:33648–33657. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Young B, Purcell C, Kuang YQ, Charette N
and Dupré DJ: Superoxide dismutase 1 regulation of CXCR4-mediated
signaling in prostate cancer cells is dependent on cellular
oxidative state. Cell Physiol Biochem. 37:2071–2084. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang S, Wang Y, Chen M, Sun L, Han J,
Elena VK and Qiao H: CXCL12 methylation-mediated epigenetic
regulation of gene expression in papillary thyroid carcinoma. Sci
Rep. 7:440332017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, Teng F, Wang G and Nie Z:
Overexpression of CXCR7 induces angiogenic capacity of human
hepatocellular carcinoma cells via the AKT signaling pathway. Oncol
Rep. 36:2275–2281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo JC, Li J, Zhou L, Yang JY, Zhang ZG,
Liang ZY, Zhou WX, You L, Zhang TP and Zhao YP: CXCL12-CXCR7 axis
contributes to the invasive phenotype of pancreatic cancer.
Oncotarget. 7:62006–62018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wurth R, Barbieri F, Bajetto A, Pattarozzi
A, Gatti M, Porcile C, Zona G, Ravetti JL, Spaziante R and Florio
T: Expression of CXCR7 chemokine receptor in human meningioma cells
and in intratumoral microvasculature. J Neuroimmunol. 234:115–123.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Totonchy JE, Osborn JM, Botto S, Clepper L
and Moses AV: Aberrant proliferation in CXCR7+ endothelial cells
via degradation of the retinoblastoma protein. PloS One.
8:e698282013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barbieri F, Thellung S, Würth R, Gatto F,
Corsaro A, Villa V, Nizzari M, Albertelli M, Ferone D and Florio T:
Emerging targets in pituitary adenomas: Role of the CXCL12/CXCR4-R7
System. Int J Endocrinol. 2014:7535242014. View Article : Google Scholar : PubMed/NCBI
|
